Tag Archive | "reduce risk of prostate cancer"

A Review on Diet and Prostate Cancer

After lung cancer, prostate cancer is the second leading cause of cancer deaths in men. The older the men get, the higher the occurrence of the disease.

If you have prostate cancer or want to prevent prostate cancer there are numerous information that has looked at diet and prostate cancer. Although some data are compelling, there is still so much to learn about diet and prostate cancer.

You might have already come across the tips below; it might not most likely reduce your risk to the disease but it should improve your health in general.

1. Maintain a diet rich in vegetables, fruits and whole grain.
Cruciferous vegetables such as broccoli, cabbage and cauliflower reduced the risk of prostate cancer by 41% according to a new study from the Fred Hutchinson Cancer Research Center in Seattle. These vegetables boast two phytochemicals which are thought to help deactivate cancer-causing substances. Lycopene present in tomatoes and other red fruits have been linked to lower risk of prostate cancer. A tablespoon of ground flaxseed a day contributes to 3 grams of fiber along with healthy omega-3 fatty acids, phytoestrogens and phytochemicals.

2. Stay away from red meat and refined/processed carbohydrates.
Eat fish a couple of times a week instead. Fish have the so called long chain omega-3 which helps stop the development of cancer. Saturated fats in animal meats and dairy products and processed foods that use hydrogenated fats/oils may help promote prostate cancer.

3. Engage in moderate intensity physically active at least 30 minutes a day.
You can also engage in vigorous-intensity physical activity at least 20 minutes on three or more days of the week. One recent study suggested that regular vigorous activity could slow the progression of prostate cancer in men age 65 or older

Posted in Prostate HealthComments Off

Experts Disagree on Prostate Cancer Prevention Drugs

Prostate cancer is the second-leading cause of cancer death in men. However, there is good news.  Drugmaker GlaxoSmithKline (GSK) produces a medicine called Avodart, generically known as dutasteride, which can reduce your risk of developing the disease. An international, four-year, placebo-controlled and randomized study conducted by GSK revealed that dutasteride cut the risk of prostate cancer by 23% — a fantastic result. However, despite these findings, many medical professionals advise against prescribing this drug. In an editorial by published in The New England Journal of Medicine, Dr. Patrick Walsh raises several issues regarding the study and its conclusions.

Walsh questions whether the dutasteride-prevented cancers were clinically significant. While the drug did lead to a significant reduction in low-grade prostate cancer incidence, the more lethal, higher-grade cancers were mostly not affected. Also disconcerting was an increase in heart failure discovered among patients taking dutasteride.

Finally, Walsh questions the study’s conclusions. He believes the drug doesn’t prevent cancer, but only temporarily shrinks tumors that have a low potential for being lethal. While the drugs do successfully treat prostate conditions by reducing prostate-specific antigen levels and shrinking the gland, he worries that the drug lead to worse problems later on by lulling men into a false sense of security.

However, the study’s lead author Dr. Gerald Andriole, chief of urological surgery at Washington University School of Medicine, disagrees. “The major problems with screening for prostate cancer using PSA . . . is what has been referred to “overdiagnosis” and “overtreatment,” he notes. As well as preventing BPH-related problems, “both finasteride and dutasteride actually improve the ability of PSA [tests] to detect the most aggressive cancers,” a desirable outcome of the study that will be reported in a later paper, and one that could reduce the chance of overdiagnosis. Instead, he recommends that PSA tests be used differently for men on the drugs, adjusting for the expected lower levels shown in patients taking dutasteride and finasteride.

Men worried about prostate cancer will likely rejoice to hear that they might be able to reduce their risk. However, the experts still disagree on the drug’s effectiveness, or even safety. As always, the best plan of action is to discuss treatment options with your doctor or medical health professional.

Posted in Chronic Prostatitis, Prostate TreatmentComments (2)


April 2021
« May